英和和英

名詞

abrocitinib (uncountable)

1. (pharmacology) A medication belonging to the class of Janus kinase inhibitors, used for the treatment of atopic dermatitis.
   • 2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172:

     Another JAK1-selective jakinib, abrocitinib, has been evaluated in phase III trials in atopic dermatitis and plaque psoriasis (61, 62), showing efficacy in both diseases. AEs included herpes simplex and herpes zoster infection, appendicitis, pancreatitis, and IBD.